Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Agnes Mwakingwe-Omari, Nicolas Lecrenier, Abdi Naficy, Desmond Curran & Inga Posiuniene. (2023) Recombinant zoster vaccine in immunocompetent and immunocompromised adults: A review of clinical studies. Human Vaccines & Immunotherapeutics 19:3.
Read now
Read now
Raunak Parikh, Robyn Widenmaier & Nicolas Lecrenier. (2021) A practitioner’s guide to the recombinant zoster vaccine: review of national vaccination recommendations. Expert Review of Vaccines 20:9, pages 1065-1075.
Read now
Read now
Federica Brosio, Giulia Masetti, Giulio Matteo, Armando Stefanati & Giovanni Gabutti. (2018) A novel nonlive, adjuvanted herpes zoster subunit vaccine: a report on the emerging clinical data and safety profile. Infection and Drug Resistance 11, pages 1401-1411.
Read now
Read now
Beate Zoch-Lesniak, Kristin Tolksdorf & Anette Siedler. (2018) Trends in herpes zoster epidemiology in Germany based on primary care sentinel surveillance data, 2005–2016. Human Vaccines & Immunotherapeutics 14:7, pages 1807-1814.
Read now
Read now
Anthony L. Cunningham & Thomas Heineman. (2017) Vaccine profile of herpes zoster (HZ/su) subunit vaccine. Expert Review of Vaccines 16:7, pages 661-670.
Read now
Read now
Articles from other publishers (31)
Anja Kwetkat, Andreas Leischker, Anne-Sophie Endres & Hans Jürgen Heppner. (2023) Impfen im Alter: eine ÜbersichtVaccination in old age: an overview. Zeitschrift für Gerontologie und Geriatrie 56:8, pages 679-687.
Crossref
Crossref
Ankur Ralhan & Adil Al-Mehiawi. (2023) Bilateral sequential acute retinal necrosis following administration of an adjuvanted recombinant subunit vaccine for herpes zoster. Canadian Journal of Ophthalmology.
Crossref
Crossref
Ernest Kuchar, Lidia Rudnicka, Magdalena Kocot-Kępska, Aneta Nitsch-Osuch, Konrad Rejdak, Jacek Wysocki, Aleksander Biesiada, Justyna Ledwoch, Dominik Wawrzuta, Agnieszka Mastalerz-Migas, Leszek Szenborn, Anna Przeklasa-Muszyńska, Alina Kułakowska, Anna Wojas-Pelc, Barbara Zegarska, Zygmunt Adamski, Roman Nowicki & Joanna Czuwara. (2023) Herpes zoster vaccination recommendations ofthe group of experts of the Polish Society of Vaccinology,the Polish Society of Family Medicine, the Polish Societyof Dermatology, the Polish Association for the Studyof Pain and the Polish Neurological Society. BÓL 24:2, pages 14-21.
Crossref
Crossref
Giulia Ellen Alves de Oliveira & Igor Marcelo Castro e Silva. (2023) Herpes Zoster em idosos: uma visão acerca da prevenção. ID on line. Revista de psicologia 17:66, pages 318-330.
Crossref
Crossref
Binshan Jiang, Qing Wang, Zhenzhong Wang, Yunshao Xu, Tao Yang, Weizhong Yang, Mengmeng Jia & Luzhao Feng. (2022) Willingness to accept herpes zoster vaccines and the influencing factors in China. BMC Infectious Diseases 22:1.
Crossref
Crossref
Georgi Vasilev, Plamena Kabakchieva, Dimitrina Miteva, Hristiana Batselova & Tsvetelina Velikova. (2022) Effectiveness and safety of COVID-19 vaccines in patients with diabetes as a factor for vaccine hesitancy. World Journal of Diabetes 13:9, pages 738-751.
Crossref
Crossref
Tetsuo Nakayama, Akihito Sawada & Takeshi Ito. (2022) Increased Production of Inflammatory Cytokines after Inoculation with Recombinant Zoster Vaccine in Mice. Vaccines 10:8, pages 1339.
Crossref
Crossref
Nalinee Chuanchaiyakul, Nuntakorn Thongtang & Pinyo Rattanaumpawan. (2022) Cumulative incidence of and risk factors for herpes zoster among patients with diabetes mellitus: Results from a 10-year nested case-control study. Journal of Diabetes and its Complications 36:5, pages 108168.
Crossref
Crossref
Jiahui Qian, Kristine Macartney, Anita Elizabeth Heywood, Sarah Sheridan & Bette Liu. (2021) Risk of recurrent herpes zoster in a population-based cohort study of older adults. Journal of the American Academy of Dermatology 85:3, pages 611-618.
Crossref
Crossref
Anja Kwetkat, Hans Jürgen Heppner, Anne-Sophie Endre & Andreas H. Leischker. (2021) Neue Empfehlungen der STIKO zum Impfen im AlterCurrent recommendations for vaccination in older adults. MMW - Fortschritte der Medizin 163:10, pages 42-49.
Crossref
Crossref
Anthony L Cunningham, Peter McIntyre, Kanta Subbarao, Robert Booy & Myron J Levin. (2021) Vaccines for older adults. BMJ, pages n188.
Crossref
Crossref
Becky Mingyao Ma, Desmond Yat Hin Yap, Terence Pok Siu Yip, Ivan Fan Ngai Hung, Sydney Chi Wai Tang & Tak Mao Chan. (2020) Vaccination in patients with chronic kidney disease—Review of current recommendations and recent advances. Nephrology 26:1, pages 5-11.
Crossref
Crossref
Anja Kwetkat, Anne-Sophie Endres, Andreas Leischker & Hans Jürgen Heppner. (2020) Impfen im Alter – Pflicht oder Kür?. DMW - Deutsche Medizinische Wochenschrift 145:16, pages 1133-1137.
Crossref
Crossref
Morgan A. Monslow, Sayda Elbashir, Nicole L. Sullivan, David S. Thiriot, Patrick Ahl, Jeff Smith, Elise Miller, James Cook, Scott Cosmi, Elizabeth Thoryk, Michael Citron, Nithya Thambi, Christine Shaw, Daria Hazuda & Kalpit A. Vora. (2020) Immunogenicity generated by mRNA vaccine encoding VZV gE antigen is comparable to adjuvanted subunit vaccine and better than live attenuated vaccine in nonhuman primates. Vaccine 38:36, pages 5793-5802.
Crossref
Crossref
Sophia Mohme, Marc Schmalzing, Cornelia S. L. Müller, Thomas Vogt, Matthias Goebeler & Johanna Stoevesandt. (2020) Impfen bei Immunsuppression: ein Leitfaden für die dermatologische Praxis. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18:7, pages 699-725.
Crossref
Crossref
Sophia Mohme, Marc Schmalzing, Cornelia S.L. Müller, Thomas Vogt, Matthias Goebeler & Johanna Stoevesandt. (2020) Immunizations in immunocompromised patients: a guide for dermatologists. JDDG: Journal der Deutschen Dermatologischen Gesellschaft 18:7, pages 699-723.
Crossref
Crossref
Joseph P. Fava, Brittany Stewart, Kathryn M. Dudzinski, Michelle Baker & Lucio Volino. (2018) Emerging Topics in Vaccine Therapeutics for Adolescents and Adults: An Update for Immunizing Pharmacists. Journal of Pharmacy Practice 33:2, pages 192-205.
Crossref
Crossref
Mandy D. Short & Christina Fergus. (2019) Which patients should receive the herpes zoster vaccine?. JAAPA 32:9, pages 18-20.
Crossref
Crossref
Kenneth E Schmader, Myron J Levin, Katrijn Grupping, Sean Matthews, David Butuk, Michael Chen, Mohamed El Idrissi, Laurence A Fissette, Charles Fogarty, Paul Hartley, Nicola P Klein, Max Nevarez, Kari Uusinarkaus, Lidia Oostvogels & Desmond Curran. (2019) The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial. The Journals of Gerontology: Series A 74:8, pages 1217-1224.
Crossref
Crossref
A. Siedler, J. Koch, E. Garbe, H. Hengel, R. von Kries, T. Ledig, T. Mertens, F. Zepp & K. Überla. (2019) Background paper to the decision to recommend the vaccination with the inactivated herpes zoster subunit vaccine. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 62:3, pages 352-376.
Crossref
Crossref
Rickard Nordén, Jonas Nilsson, Ebba Samuelsson, Christian Risinger, Carina Sihlbom, Ola Blixt, Göran Larson, Sigvard Olofsson & Tomas Bergström. (2019) Recombinant Glycoprotein E of Varicella Zoster Virus Contains Glycan-Peptide Motifs That Modulate B Cell Epitopes into Discrete Immunological Signatures. International Journal of Molecular Sciences 20:4, pages 954.
Crossref
Crossref
Yahiya Y. Syed. (2018) Recombinant Zoster Vaccine (Shingrix®): A Review in Herpes Zoster. Drugs & Aging 35:12, pages 1031-1040.
Crossref
Crossref
Peter Wutzler, Giacomo Casabona, Jennifer Cnops, Esse Ifebi Herve Akpo & Marco Aurelio P. Safadi. (2018) Herpes zoster in the context of varicella vaccination – An equation with several variables. Vaccine 36:46, pages 7072-7082.
Crossref
Crossref
. (2018) Policy Statement. Ophthalmology 125:11, pages 1813-1816.
Crossref
Crossref
Anthony L Cunningham & Myron J Levin. (2018) Herpes Zoster Vaccines. The Journal of Infectious Diseases 218:suppl_2, pages S127-S133.
Crossref
Crossref
Georges Kosmadakis, Julie Albaret, Enrique Da Costa Correia, Frederic Somda & Didier Aguilera. (2018) Vaccination practices in dialysis patients: A narrative review. Seminars in Dialysis 31:5, pages 507-518.
Crossref
Crossref
Edmund Tsui & Elisabeth J. Cohen. (2018) The Importance of Vaccination Against Herpes Zoster. Current Ophthalmology Reports 6:3, pages 173-180.
Crossref
Crossref
Allister Gibbons & Anat Galor. (2018) Current vaccines for the prevention of herpes zoster. Current Opinion in Ophthalmology 29:4, pages 355-359.
Crossref
Crossref
Melanie R. SymoniakPejman FarrokhMona A. GandhiJudianne C. Slish. (2018) Herpes zoster subunit vaccine for the prevention of herpes zoster. American Journal of Health-System Pharmacy 75:12, pages 861-869.
Crossref
Crossref
Marieke van der Heiden, Lia G. H. de Rond, Menno C. van Zelm, Guy A. M. Berbers, Annemieke M. H. Boots & Anne-Marie Buisman. (2018) Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults. Frontiers in Immunology 9.
Crossref
Crossref
Amrita R. John & David H. Canaday. (2017) Herpes Zoster in the Older Adult. Infectious Disease Clinics of North America 31:4, pages 811-826.
Crossref
Crossref